CNC vs ISPC · P/E 8.4, rev $163.07B vs rev $9.3M
Centene Corp (CNC) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the CNC and ISPC stock pages for the full models.
Not investment advice.